Neuropeptide Y and osteoblast differentiation – the balance between the neuro‐osteogenic network and local control

Accumulating evidence has contributed to a novel view in bone biology: bone remodeling, specifically osteoblast differentiation, is under the tight control of the central and peripheral nervous systems. Among other players in this neuro‐osteogenic network, the neuropeptide Y (NPY) system has attracted particular attention. At the central nervous system level, NPY exerts its function in bone homeostasis through the hypothalamic Y2 receptor. Locally in the bone, NPY action is mediated by its Y1 receptor. Besides the presence of Y1, a complex network exists locally: not only there is input of the peripheral nervous system, as the bone is directly innervated by NPY‐containing fibers, but there is also input from non‐neuronal cells, including bone cells capable of NPY expression. The interaction of these distinct players to achieve a multilevel control system of bone homeostasis is still under debate. In this review, we will integrate the current knowledge on the impact of the NPY system in bone biology, and discuss the mechanisms through which the balance between central and the peripheral NPY action might be achieved.

[1]  P. Baldock,et al.  Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  C. Östenson,et al.  Bone and joint neuropathy in rats with type-2 diabetes , 2004, Regulatory Peptides.

[3]  R. Jilka,et al.  Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. , 2005, Endocrinology.

[4]  H. Herzog,et al.  Inhibitory effects of central neuropeptide Y on the somatotropic and gonadotropic axes in male rats are independent of adrenal hormones , 2001, Peptides.

[5]  R. Palmiter,et al.  Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y , 1996, Science.

[6]  R. Pacifici Editorial: Cytokines, Estrogen, and Postmenopausal Osteoporosis-The Second Decade. , 1998, Endocrinology.

[7]  M. Myers,et al.  Molecular and neural mediators of leptin action , 2008, Physiology & Behavior.

[8]  R. Turner,et al.  Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats , 1991, Neuroscience.

[9]  R. Mains,et al.  The biosynthesis of neuropeptides: peptide alpha-amidation. , 1992, Annual review of neuroscience.

[10]  S. Prigge,et al.  New insights into copper monooxygenases and peptide amidation: structure, mechanism and function , 2000, Cellular and Molecular Life Sciences CMLS.

[11]  Takao Shimizu,et al.  Identification of Two Isoforms of Mouse Neuropeptide Y-Y1 Receptor Generated by Alternative Splicing , 1995, The Journal of Biological Chemistry.

[12]  M. Fitzgerald,et al.  Development of peripheral hindlimb and central spinal cord innervation by subpopulations of dorsal root ganglion cells in the embryonic rat , 2000, The Journal of comparative neurology.

[13]  R. Pacifici Cytokines, estrogen, and postmenopausal osteoporosis--the second decade. , 1998, Endocrinology.

[14]  J. Eisman,et al.  Greater Bone Formation of Y2 Knockout Mice Is Associated with Increased Osteoprogenitor Numbers and Altered Y1 Receptor Expression* , 2007, Journal of Biological Chemistry.

[15]  E. Theodorsson,et al.  Extraction and quantitation of neuropeptides in bone by radioimmunoassay , 1994, Regulatory Peptides.

[16]  M. Sousa,et al.  Neuropeptide Y expression and function during osteoblast differentiation – insights from transthyretin knockout mice , 2010, The FEBS journal.

[17]  T. O'donohue,et al.  The anatomy of neuropeptide-y-containing neurons in rat brain , 1985, Neuroscience.

[18]  T. J. Thurston Distribution of nerves in long bones as shown by silver impregnation. , 1982, Journal of anatomy.

[19]  P. Alberius,et al.  Adrenergic innervation of the calvarium of the neonatal rat , 2004, Anatomy and Embryology.

[20]  V. Mutt,et al.  Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide , 1982, Nature.

[21]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[22]  Takao Shimizu,et al.  Identification of Two Isoforms of Mouse Neuropeptide YY 1 Receptor Generated by Alternative Splicing ISOLATION , 1995 .

[23]  C. Schwarzer,et al.  Synergistic Effects of Y2 and Y4 Receptors on Adiposity and Bone Mass Revealed in Double Knockout Mice , 2003, Molecular and Cellular Biology.

[24]  M. Schultzberg,et al.  Neuropeptide Y, Tyrosine Hydroxylase and Vasoactive Intestinal Polypeptide‐Immunoreactive Nerve Fibers in the Vertebral Bodies, Discs, Dura Mater, and Spinal Ligaments of the Rat Lumbar Spine , 1993, Spine.

[25]  A. Bjurholm Neuroendocrine peptides in bone , 2004, International Orthopaedics.

[26]  Arndt F Schilling,et al.  Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.

[27]  A. Gundlach,et al.  Expression of galanin and galanin receptor-1 in normal bone and during fracture repair in the rat. , 2003, Bone.

[28]  J. Eisman,et al.  Critical Interplay Between Neuropeptide Y and Sex Steroid Pathways in Bone and Adipose Tissue Homeostasis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  R. Burstein,et al.  Sensory innervation of the calvarial bones of the mouse , 2009, The Journal of comparative neurology.

[30]  A. Zengin,et al.  Neuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat , 2010, Trends in Endocrinology & Metabolism.

[31]  D. Adriaensen,et al.  Development of sensory innervation in rat tibia: co‐localization of CGRP and substance P with growth‐associated protein 43 (GAP‐43) , 2005, Journal of anatomy.

[32]  L. Terenius,et al.  Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. , 1988, Journal of the autonomic nervous system.

[33]  S. Takeda,et al.  Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass. , 2003, Endocrinology.

[34]  M. Kneissel,et al.  SOST is a target gene for PTH in bone. , 2005, Bone.

[35]  M. Bouxsein,et al.  Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes , 2008, PloS one.

[36]  Xi Jiang,et al.  Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity , 2009, Journal of cellular biochemistry.

[37]  M. Sherman The Nerves of Bone , 1963 .

[38]  T. Nagatsu,et al.  Expression of mRNAs for neuropeptide receptors and β-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells , 1997, Neuroscience Letters.

[39]  S. Allison,et al.  The control of bone remodeling by neuropeptide Y receptors , 2007, Peptides.

[40]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[41]  J. Eisman,et al.  Neuropeptide Y Knockout Mice Reveal a Central Role of NPY in the Coordination of Bone Mass to Body Weight , 2009, PloS one.

[42]  Kevin B. Jones,et al.  Bone and brain: a review of neural, hormonal, and musculoskeletal connections. , 2004, The Iowa orthopaedic journal.

[43]  F. Pralong,et al.  Neuropeptide Y: the universal soldier , 2003, Cellular and Molecular Life Sciences CMLS.

[44]  A. Kuntz,et al.  Innervation of the bone marrow , 1945, The Journal of comparative neurology.

[45]  L. Kruger,et al.  Calcitonin‐gene‐related‐peptide‐immunoreactive innervation of the rat head with emphasis on specialized sensory structures , 1989, The Journal of comparative neurology.

[46]  A. Sainsbury,et al.  Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue , 1996, Diabetologia.

[47]  M. Schultzberg,et al.  Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR‐106–01, ROS 17/2.8, MC3T3‐E1, and Saos‐2) and primary bone cells , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[48]  Minqi Li,et al.  Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. , 2007, Cell metabolism.

[49]  Thurston Tj Distribution of nerves in long bones as shown by silver impregnation. , 1982 .

[50]  Matthew R Allen,et al.  Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin* , 2008, Journal of Biological Chemistry.

[51]  T. Nagao,et al.  Pancreatic polypeptide is secreted from and controls differentiation through its specific receptors in osteoblastic MC3T3-E1 cells , 2008, Peptides.

[52]  M. Sousa,et al.  NPY revealed as a critical modulator of osteoblast function in vitro: New insights into the role of Y1 and Y2 receptors , 2009, Journal of cellular biochemistry.

[53]  G. Thomas,et al.  Hypothalamic Y2 receptors regulate bone formation. , 2002, The Journal of clinical investigation.

[54]  M. Ghatei,et al.  Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. , 1993, Endocrinology.

[55]  W. Calvo,et al.  On the development of bone marrow innervation in new-born rats as studied with silver impregnation and electron microscopy. , 1969, The American journal of anatomy.

[56]  J. Bue-Valleskey,et al.  The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.

[57]  S. Woods,et al.  Estradiol-Dependent Decrease in the Orexigenic Potency of Ghrelin in Female Rats , 2007, Diabetes.

[58]  M. Sousa,et al.  Transthyretin knockouts are a new mouse model for increased neuropeptide Y , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  C. Bünger,et al.  Vasoconstrictive action of neuropeptide Y in bone. The porcine tibia perfused in vivo. , 1994, Acta orthopaedica Scandinavica.

[60]  U. Lerner The Role of Skeletal Nerve Fibers in Bone Metabolism , 2000 .

[61]  Patricia Ducy,et al.  Leptin Regulates Bone Formation via the Sympathetic Nervous System , 2002, Cell.

[62]  Wei Yao,et al.  Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. , 2008, Bone.

[63]  S. Allison,et al.  Hypothalamic Control of Bone Formation: Distinct Actions of Leptin and Y2 Receptor Pathways , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[64]  J. Eisman,et al.  Hypothalamic Regulation of Cortical Bone Mass: Opposing Activity of Y2 Receptor and Leptin Pathways , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[65]  J. Eisman,et al.  Novel Role of Y1 Receptors in the Coordinated Regulation of Bone and Energy Homeostasis* , 2007, Journal of Biological Chemistry.

[66]  G. Karsenty,et al.  The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.

[67]  Malcolm R. Miller,et al.  Observations on the innervation of human long bones , 1963 .

[68]  Rene Devos,et al.  Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.

[69]  C. Schwarzer,et al.  Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. , 2002, Diabetes.

[70]  A. Kreicbergs,et al.  The development of autonomic innervation in bone and joints of the rat. , 1996, Journal of the autonomic nervous system.

[71]  D. Larhammar,et al.  Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[72]  R. Elde,et al.  Distribution of CGRP-, VIP-, DβH-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat , 1991, Cell and Tissue Research.

[73]  P. Mantyh,et al.  Peripheral patterns of calcitonin‐gene‐related peptide general somatic sensory innervation: Cutaneous and deep terminations , 1989, The Journal of comparative neurology.

[74]  J. Eisman,et al.  Conditional Deletion of Hypothalamic Y2 Receptors Reverts Gonadectomy-induced Bone Loss in Adult Mice* , 2006, Journal of Biological Chemistry.